Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Catheter Cardiovasc Interv. 2021 Jun 19;98(5):959–968. doi: 10.1002/ccd.29842

TABLE 2.

Clinical outcomes and resource utilization in the unadjusted and propensity-matched cohorts in the transcatheter aortic valve replacement (TAVR) procedure performed without and with cerebral protection device

Unadjusted
Matched (1:3 Propensity match)
Variable n (%)a TAVR without CPD (103,935) TAVR with CPD (4380) p value TAVR without CPD (13,140) TAVR with CPD (4380) p value
In-hospital mortality 1510(1.5) 20(0.5) <0.01 135(1.0) 20(0.5) <0.01
Discharge disposition
 Routine 68,755(66.2) 3145(71.8) <0.01 8710(66.3) 3145(71.8) <0.01
 Short term care hospital 400(0.4) <11(<0.2) 35(0.3) <11(<0.3)
 Home health care 20,215(19.4) 770(17.6) 2580(19.6) 770(17.6)
Complications and resource utilization
 Cardiogenic shock 2050(2.0) 60(1.4) 0.01 170(1.3) 60(1.4) 0.7
 Respiratory complications 6525(6.3) 170(3.9) <0.01 745(5.7) 170(3.9) <0.01
 Acute kidney injury 11,070(10.7) 355(8.1) <0.01 1190(9.1) 355(8.1) 0.05
 Neurological complications 2600(2.5) 75(1.7) <0.01 340(2.6) 75(1.7) <0.01
 Hemorrhagic stroke 115(0.1) - 0.03 20(0.2) - 0.01
 Ischemic stroke 2070(2.0) 60(1.4) <0.01 270(2.1) 60(1.4) <0.01
 Transient ischemic attack 305(0.3) <11(<0.2) 0.43 40(0.3) <11(<0.3) 0.41
 Vascular complications 4380(4.2) 175(4.0) 0.48 540(4.1) 175(4.0) 0.74
 Major bleeding 1070(1.0) 25(0.6) 0.003 95(0.7) 25(0.6) 0.29
 Cardiac arrest with CPR 1290(1.2) 20(0.5) <0.01 125(1.0) 20(0.5) <0.01
 Prolong mechanical vent 965(0.9) 15(0.3) <0.01 525(4.0) 155(3.5) 0.04
 Short term intubation 3905(3.8) 140(3.2) 0.06 525(4.0) 155(3.5) 0.18
 Permanent pacemakers 10,405(10.0) 425(9.7) 0.51 1315(10.0) 425(9.7) 0.56
 Length of stay, median (IQR), days 2(1–4) 2(1–4) <0.01 2(1–4) 2(1–4) <0.01
 Cost of hospitalization, median (IQR) $ 44,880(35,113–57,230) 44,861(36,953–57,254) <0.01 44,881(35,113–57,231) 44,861(36,953–57,255) <0.01

Abbreviations: CPD, cerebral protection device; TAVR; transcatheter aortic valve replacement.

Note: Major bleeding requiring blood transfusion.

a

<11 numbers not reported per HCUP recommendations.